Article Details

Biocytogen and Hansoh Pharma Announce an Antibody License Agreement - Business Wire India

Retrieved on: 2023-01-03 04:38:33

Tags for this article:

Click the tags to see associated articles and topics

Biocytogen and Hansoh Pharma Announce an Antibody License Agreement - Business Wire India. View article details on HISWAI: https://www.businesswireindia.com/biocytogen-and-hansoh-pharma-announce-an-antibody-license-agreement-82396.html

Excerpt

Using its proprietary RenMab™/RenLite®/RenNano® mice platforms for fully human monoclonal, bispecific/multispecific antibody and nanobody ...

Article found on: www.businesswireindia.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up